HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank

Archives of Neurology

Volumn 61, Issue 4, 2004, Pages 546-551

  Morgello, Susan ^a   Estanislao, Lydia ^a   Simpson, David ^a   Geraci, Anthony ^a,b   DiRocco, Alessandro ^a,b   Gerits, Pieter ^a   Ryan, Elizabeth ^a   Yakoushina, Tatiana ^a   Khan, Shafat ^a   Mahboob, Rashid ^a   Naseer, Mubasher ^a   Dorfman, David ^a   Sharp, Victoria ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; OPIATE; PSYCHEDELIC AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; SEDATIVE AGENT;

ACHILLES REFLEX; ADULT; ARTICLE; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NOCICEPTION; PAIN; PARESTHESIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; SUBSTANCE ABUSE; SURAL NERVE; VIRUS LOAD; ADDICTION; ANKLE; CROSS-SECTIONAL STUDY; INNERVATION; MIDDLE AGED; NEURITIS; NEUROLOGIC EXAMINATION; PATHOLOGY; POLYNEUROPATHY; RISK FACTOR;

ADULT; ANKLE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEURITIS; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SURAL NERVE;

EID: 2342472645     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.4.546     Document Type: Article

References (19)

1. Brinley FJ Jr, Pardo CA, Verma A. Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol. 2001;58:1561-1566.
2. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst. 2001;6:21-27.
3. HIV/AIDS Surveillance Program NYCDoH. Surveillance update, including persons living with AIDS in New York City. HIV/AIDS Semi-Annual Rep. June 2002:1-31.
4. McArthur J, McClernon D, McDermott M, et al. Viral load markers and neurological status: a report from the North-East Dementia cohort [abstract]. J Neurovirol. 2002;8(suppl 1):10.
5. Simpson DM, Haidich AB, Schifitto G, et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. 2002;16:407-412.
6. Simpson DM, Katzenstein DA, Hughes MD, et al, AIDS Clinical Group 175/801 Study Team. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS. 1998;12:2425-2432.
7. Tagliati M, Grinnell J, Godbold J, Simpson DM. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999;56:84-89.
8. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin. 1992;10:685-711.
9. Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 2002;58:1764-1768.
10. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996;153:1195-1201.
11. McArthur JC. Neurologic manifestations of AIDS. Medicine. 1987;66:407-437.
12. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983;14:403-418.
13. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: Influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med. 2002;126:182-190.
14. McArthur JC, Yiannoutsos C, Simpson DM, et al, AIDS Clinical Trials Group Team 291. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection [published correction appears in Neurology. 2000;55:162]. Neurology. 2000;54:1080-1088.
15. McArthur JC, Yiannoutsos C, Simpson DM, et al, AIDS Clinical Trials Group Team 291. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection [published correction appears in Neurology. 2000;55:162]. Neurology. 2000;54:1080-1088.
16. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613.
17. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:153-161.
18. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001;63:139-146.
19. Swica Y, Breitbart W. Treating pain in patients with AIDS and a history of substance use. West J Med. 2002;176:33-39.